These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37085507)

  • 1. Predictors of Lassa fever diagnosis in suspected cases reporting to health facilities in Nigeria.
    Ochu CL; Ntoimo L; Onoh I; Okonofua F; Meremikwu M; Mba S; Iniobong A; Nwafor O; Dalhat M; Ohonsi C; Arinze C; Esu E; Igumbor EU; Dan-Nwafor C; Ilori E; Adetifa I
    Sci Rep; 2023 Apr; 13(1):6545. PubMed ID: 37085507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trend of Lassa fever cases and factors associated with mortality in Liberia, 2016 - 2021: a secondary data analysis.
    Dwalu E; Jetoh RW; Shobayo BI; Pewu I; Taweh F; Wilson-Sesay HW; Akpan GE; Shannon F; Joseph BO; Umeokonkwo CD; Adewuyi P; Amo-Addae M; Nagbe TK; Gilayeneh J; MaCauley JA
    Pan Afr Med J; 2024; 47():22. PubMed ID: 38558556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of sociodemographic and clinical factors associated with Lassa fever disease and mortality in Nigeria.
    Olayinka AT; Elimian K; Ipadeola O; Dan-Nwafor C; Gibson J; Ochu C; Furuse Y; Iniobong A; Akano A; Enenche L; Onoja M; Uzoho C; Ugbogulu N; Makava F; Arinze C; Namara G; Muwanguzi E; Jan K; Ukponu W; Okwor T; Anueyiagu C; Saleh M; Ahumibe A; Eneh C; Ilori E; Mba N; Ihekweazu C
    PLOS Glob Public Health; 2022; 2(8):e0000191. PubMed ID: 36962735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological trends of Lassa fever in Nigeria, 2018-2021.
    Dalhat MM; Olayinka A; Meremikwu MM; Dan-Nwafor C; Iniobong A; Ntoimo LF; Onoh I; Mba S; Ohonsi C; Arinze C; Esu EB; Nwafor O; Oladipupo I; Onoja M; Ilori E; Okonofua F; Ochu CL; Igumbor EU; Adetifa I
    PLoS One; 2022; 17(12):e0279467. PubMed ID: 36584167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological characteristics of Lassa fever cases in Liberia: a retrospective analysis of surveillance data, 2019-2020.
    Jetoh RW; Malik S; Shobayo B; Taweh F; Yeabah TO; George J; Gbelee B; Teahton J; Jaryan F; Tegli M; Umeokonkwo CD; MaCauley J
    Int J Infect Dis; 2022 Sep; 122():767-774. PubMed ID: 35817283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge and risk perception towards Lassa fever infection among residents of affected communities in Ebonyi State, Nigeria: implications for risk communication.
    Usuwa IS; Akpa CO; Umeokonkwo CD; Umoke M; Oguanuo CS; Olorukooba AA; Bamgboye E; Balogun MS
    BMC Public Health; 2020 Feb; 20(1):217. PubMed ID: 32050926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with progression to death in patients with Lassa fever in Nigeria: an observational study.
    Strampe J; Asogun DA; Speranza E; Pahlmann M; Soucy A; Bockholt S; Pallasch E; Becker-Ziaja B; Duraffour S; Bhadelia N; Ighodalo Y; Oyakhilome J; Omomoh EO; Olokor T; Adomeh DI; Ikponwonsa O; Aire C; Tobin E; Akpede N; Okokhere PO; Okogbenin SA; Akpede GO; Muñoz-Fontela C; Ogbaini-Emovon E; Günther S; Connor JH; Oestereich L
    Lancet Infect Dis; 2021 Jun; 21(6):876-886. PubMed ID: 33484646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cluster of nosocomial Lassa fever cases in a tertiary health facility in Nigeria: Description and lessons learned, 2018.
    Dan-Nwafor CC; Ipadeola O; Smout E; Ilori E; Adeyemo A; Umeokonkwo C; Nwidi D; Nwachukwu W; Ukponu W; Omabe E; Anaebonam U; Igwenyi N; Igbodo G; Eteng W; Uzoma I; Saleh M; Agboeze J; Mutbam S; de Gooyer T; Short R; Aniaku E; Onoh R; Ogah E; Nguku P; Oladejo J; Peter C; Ojo O; Ihekweazu C
    Int J Infect Dis; 2019 Jun; 83():88-94. PubMed ID: 30930184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1-May 6, 2018.
    Ilori EA; Furuse Y; Ipadeola OB; Dan-Nwafor CC; Abubakar A; Womi-Eteng OE; Ogbaini-Emovon E; Okogbenin S; Unigwe U; Ogah E; Ayodeji O; Abejegah C; Liasu AA; Musa EO; Woldetsadik SF; Lasuba CLP; Alemu W; Ihekweazu C;
    Emerg Infect Dis; 2019 Jun; 25(6):1066-1074. PubMed ID: 31107222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge of Lassa fever, its prevention and control practices and their predictors among healthcare workers during an outbreak in Northern Nigeria: A multi-centre cross-sectional assessment.
    Wada YH; Ogunyinka IA; Yusuff KB; Ochu CL; Yahaya M; Khalid GM; Mutalub YB; Adeniye SB
    PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010259. PubMed ID: 35286303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lassa fever in post-conflict sierra leone.
    Shaffer JG; Grant DS; Schieffelin JS; Boisen ML; Goba A; Hartnett JN; Levy DC; Yenni RE; Moses LM; Fullah M; Momoh M; Fonnie M; Fonnie R; Kanneh L; Koroma VJ; Kargbo K; Ottomassathien D; Muncy IJ; Jones AB; Illick MM; Kulakosky PC; Haislip AM; Bishop CM; Elliot DH; Brown BL; Zhu H; Hastie KM; Andersen KG; Gire SK; Tabrizi S; Tariyal R; Stremlau M; Matschiner A; Sampey DB; Spence JS; Cross RW; Geisbert JB; Folarin OA; Happi CT; Pitts KR; Geske FJ; Geisbert TW; Saphire EO; Robinson JE; Wilson RB; Sabeti PC; Henderson LA; Khan SH; Bausch DG; Branco LM; Garry RF;
    PLoS Negl Trop Dis; 2014 Mar; 8(3):e2748. PubMed ID: 24651047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with delayed presentation to healthcare facilities for Lassa fever cases, Nigeria 2019: a retrospective cohort study.
    Chandra NL; Bolt H; Dan-Nwafor C; Ipadeola O; Ilori E; Namara G; Olayinka AT; Ukponu W; Iniobong A; Amedu M; Akano A; Akabike KO; Okhuarobo U; Fagbemi S; Sampson E; Newitt S; Verlander NQ; Bausch DG; le Polain de Waroux O; Ihekweazu C
    BMC Infect Dis; 2021 Feb; 21(1):143. PubMed ID: 33541278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ecological correlates and predictors of Lassa fever incidence in Ondo State, Nigeria 2017-2021: an emerging urban trend.
    Cadmus S; Taiwo OJ; Akinseye V; Cadmus E; Famokun G; Fagbemi S; Ansumana R; Omoluabi A; Ayinmode A; Oluwayelu D; Odemuyiwa S; Tomori O
    Sci Rep; 2023 Nov; 13(1):20855. PubMed ID: 38012226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection pattern, case fatality rate and spread of Lassa virus in Nigeria.
    Yaro CA; Kogi E; Opara KN; Batiha GE; Baty RS; Albrakati A; Altalbawy FMA; Etuh IU; Oni JP
    BMC Infect Dis; 2021 Feb; 21(1):149. PubMed ID: 33546623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Containing a Lassa fever epidemic in a resource-limited setting: outbreak description and lessons learned from Abakaliki, Nigeria (January-March 2012).
    Ajayi NA; Nwigwe CG; Azuogu BN; Onyire BN; Nwonwu EU; Ogbonnaya LU; Onwe FI; Ekaete T; Günther S; Ukwaja KN
    Int J Infect Dis; 2013 Nov; 17(11):e1011-6. PubMed ID: 23871405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lassa fever cases and mortality in Nigeria: Quantile Regression vs. Machine Learning Models.
    Samson TK; Aromolaran O; Akingbade T
    J Public Health Afr; 2023 Dec; 14(12):2712. PubMed ID: 38259425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and outcome of Lassa fever among hospitalized patients in Ebonyi State, Nigeria, 2018-2019.
    Nwafor IE; Ogah OE; Ojide CK; Odeh EC; Abu AM; Chika-Igwenyi NM; Nwidi DU; Unigwe US; Ajayi NA; Eke MAS; Obasi MN; Adeke AS; Onyia V; Duruiheoma R; Igboke NC; Otti J; Ogbu O
    Virus Res; 2020 Aug; 285():198000. PubMed ID: 32380207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: a retrospective, observational cohort study.
    Okokhere P; Colubri A; Azubike C; Iruolagbe C; Osazuwa O; Tabrizi S; Chin E; Asad S; Ediale E; Rafiu M; Adomeh D; Odia I; Atafo R; Aire C; Okogbenin S; Pahlman M; Becker-Ziaja B; Asogun D; Fradet T; Fry B; Schaffner SF; Happi C; Akpede G; Günther S; Sabeti PC
    Lancet Infect Dis; 2018 Jun; 18(6):684-695. PubMed ID: 29523497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge of Lassa fever and use of infection prevention and control facilities among health care workers during Lassa fever outbreak in Ondo State, Nigeria.
    Ijarotimi IT; Ilesanmi OS; Aderinwale A; Abiodun-Adewusi O; Okon IM
    Pan Afr Med J; 2018; 30():56. PubMed ID: 30197747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research as a pillar of Lassa fever emergency response: lessons from Nigeria.
    Olayinka AT; Nwafor CD; Akano A; Jan K; Ebhodaghe B; Elimian K; Ochu C; Okwor T; Ipadeola O; Ukponu W; Okudo I; Peter C; Ilori E; Ihekweazu C
    Pan Afr Med J; 2020; 37():179. PubMed ID: 33447334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.